Amussen Hunsaker Associates LLC Gsk PLC Transaction History

Amussen Hunsaker Associates LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$38.11 - $42.99 $194,894 - $219,850	-5,114 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$37.87 - $43.58 $193,667 - $222,868	5,114 New	5,114 $209,000
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $149,362 - $224,618	-4,600 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $193,200 - $221,950	4,600 New	4,600 $216,000
Q4 2018 Feb 19, 2019	SELL	$37.8 - $42.69 $151,200 - $170,760	-4,000 Closed	0 $0
Q3 2018 Nov 16, 2018	SELL	$39.75 - $42.69 $31,800 - $34,152	-800 Reduced 16.67%	4,000 $161,000
Q2 2018 Aug 16, 2018	BUY	$39.61 - $42.76 $190,128 - $205,248	4,800 New	4,800 $193,000
Q1 2018 May 15, 2018	SELL	$36.18 - $40.15 $144,720 - $160,600	-4,000 Closed	0 $0
Q4 2017 Feb 16, 2018	BUY	$35.34 - $41.9 $141,360 - $167,600	4,000	4,000 $141,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Amussen Hunsaker Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Amussen Hunsaker Associates LLC with notifications on news.